What happened
Shares of ShockWave Medical (NASDAQ: SWAV) were soaring 17.9% higher at 11:54 a.m. ET on Tuesday. The big jump came after the company announced its second-quarter results following the market close on Monday.
ShockWave reported Q2 revenue of $120.7 million, up 116% year over year. It posted earnings of $25.6 million, or $0.68 per diluted share. This reflected significant improvement from the net loss of $0.4 million in the prior-year period. Both top- and bottom-line Q2 results handily beat consensus estimates.
In addition, ShockWave raised its full-year revenue guidance. The company now expects 2022 revenue will be between $465 million and $475 million, a 98% year-over-year increase at the midpoint of the range. ShockWave previously forecast full-year revenue of $435 million to $455 million.
So what
ShockWave was already making investors happy so far in 2022, with the healthcare stock jumping 25% year to date even before today's gain. This kind of performance during a period of economic uncertainty underscores just how much ShockWave's business is booming.
Much of the company's growth is due to the launch of its Shockwave C2 product in the U.S. last year. The product uses intravascular lithotripsy (IVL) to break up calcium deposits in patients with coronary problems.
Now what
China looks to be ShockWave's next big opportunity. The company received regulatory approval in China in May for its Shockwave IVL System with the Shockwave C2 Coronary IVL Catheters and the Shockwave M5 and S4 Peripheral IVL.
10 stocks we like better than ShockWave Medical
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and ShockWave Medical wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of July 27, 2022
Keith Speights has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ShockWave Medical. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
